Free Trial

4basebio (4BB) Insider Trading & Ownership

4basebio logo
GBX 1,170.80 -39.20 (-3.24%)
(As of 12:17 PM ET)

4basebio (LON:4BB) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
68.44%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
£616,125.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get 4BB Insider Trade Alerts

Want to know when executives and insiders are buying or selling 4basebio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

4BB Insider Buying and Selling by Quarter

4basebio Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/15/2024Heikki LanckrietInsiderBuy46,500GBX 1,325£616,125
(Data available from 1/1/2013 forward)

4BB Insider Trading Activity - Frequently Asked Questions

The list of insiders at 4basebio includes David John Roth, and Heikki Lanckriet. Learn more on insiders at 4BB.

68.44% of 4basebio stock is owned by insiders. Learn more on 4BB's insider holdings.

The following insider purchased 4BB shares in the last 24 months: Heikki Lanckriet (£616,125).

Insiders have purchased a total of 46,500 4BB shares in the last 24 months for a total of £616,125 bought.

4basebio Key Executives

  • Dr. Heikki Lanckriet Ph.D. (Age 47)
    CEO, Chief Scientific Officer & Executive Director
    Compensation: $441.2k
  • Mr. David Roth (Age 57)
    CFO, Company Secretary & Executive Director
    Compensation: $317.9k


This page (LON:4BB) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners